Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel dutasteride synthesis reduces impurities and costs significantly. Reliable supply chain partner for high-purity pharmaceutical intermediates and bulk drug manufacturing globally.
Novel five-step route avoids hazardous HMPA and cryogenic conditions. Delivers high purity pharmaceutical intermediates with scalable industrial production capabilities.
Novel synthesis of (S)/(R)-midpacamide using chiral amino acids. Solves racemization, >99% purity. Reliable supply for pharma R&D.
Novel copper-catalyzed radical tandem reaction for high-purity intermediates. Reduces waste and cost in pharmaceutical manufacturing via efficient amine hydrochloride utilization.
Advanced hydrolysis method for high-purity gabapentin. Reduces toxic impurities and energy consumption. Ideal for API manufacturing scale-up.
Novel industrial route for 2,4,5-trifluorophenylacetic acid using 2,4-dichlorotoluene. High yield, cost-effective manufacturing for DPP-4 inhibitor intermediates.
Patent CN104557725A reveals a copper-catalyzed one-pot synthesis for 1,2-diarylbenzimidazoles. This method offers mild conditions and high selectivity for pharmaceutical intermediate manufacturing.
Patent CN107805824A enables metal-free electrochemical cyclization. This reduces cost and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel patent CN106588673A details efficient synthesis route offering high yield and supply chain stability for pharmaceutical intermediate manufacturing processes globally.
Patent CN102260273B details novel anti-tumor conjugates. Discover cost-effective manufacturing and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN116262673B reveals solvent-free ball milling for alpha-bromoacetophenone. Enhances supply chain reliability and reduces environmental impact for pharmaceutical intermediates.
Novel Pd/C catalyzed method for PCUD reduction. Enhances supply chain reliability and cost efficiency for high-energy fuel and pharmaceutical applications.
Patent CN109111490B introduces a novel halogenated pivaloyl glucopyranose route for SGLT2 inhibitors, offering superior stereoselectivity and industrial scalability for pharmaceutical manufacturing.
Patent CN109280050B reveals a novel avanafil synthesis method offering high purity and cost reduction in pharmaceutical intermediates manufacturing through optimized oxidation steps.
Novel synthesis of lappaconitine acetal derivatives offers mild conditions and high safety for scalable antitumor pharmaceutical intermediates manufacturing supply chains.
Patent CN103012264A details a robust resolution method for (R)-3-amino-hexahydro-1H-azepane using tartaric acid, ensuring superior optical purity for ophthalmic antibiotics.
Patent CN106632365B reveals a novel one-pot synthesis for high-purity lappaconitine-isatin hybrids, offering significant supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel synthesis of licochalcone A dihydropyrazole derivatives. Mild conditions, scalable process for pharmaceutical intermediates. Reliable supply chain partner for global drug development.
Patent CN109593055B details a scalable resolution method for Brivaracetam isomer (2S, 4S), eliminating chromatography for cost-effective pharmaceutical intermediate manufacturing.
Patent CN109293722B details a novel synthesis for Azithromycin Impurity P using modified platinum carbon catalysis, offering reliable supply for pharmaceutical quality control.